Aprea Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Aprea Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aprea Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aprea Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $2.5k | 2.5k | 1.00 |
| 2025-09-30 | $3 | 3 | 1.33 |
| 2025-06-30 | $12 | 8 | 1.60 |
| 2025-03-31 | $6 | 3 | 2.00 |
| 2024-12-31 | $20k | 5.9k | 3.33 |
| 2024-09-30 | $8 | 3 | 2.67 |
| 2024-06-30 | $12 | 3 | 4.00 |
| 2024-03-31 | $20 | 3 | 6.67 |
| 2023-12-31 | $14 | 3 | 4.67 |
| 2023-09-30 | $12 | 3 | 4.33 |
| 2023-06-30 | $9 | 3 | 3.00 |
| 2023-03-31 | $2.9k | 674 | 4.33 |